Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in de novo liver transplant
NCT01423708Phase 2Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Feb 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Liver transplant rejection, sponsored by Azienda Ospedaliero-Universitaria di Padova. Status: unknown.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01423708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423708.